Portfolio Sync Solutions
Streamline your investment strategy with our portfolio synchronization tools. Seamlessly manage and track your holdings across platforms for enhanced
GET STARTEDActual EPS
Enzo Biochem, Inc. Analyst EPS Estimates
| Quarter | Number of Estimates | Low Estimate | High Estimate | Average Estimate |
|---|---|---|---|---|
| Q1 2025 | 1 | -$0.13 | -$0.13 | -$0.13 |
| Q2 2025 | 1 | -$0.15 | -$0.15 | -$0.15 |
| Q3 2025 | 1 | -$0.14 | -$0.14 | -$0.14 |
Enzo Biochem, Inc. Earnings Date And Information
Enzo Biochem, Inc. last posted its earnings results on Tuesday, October 15th, 2019. The company reported $-0.11 earnings per share for the quarter, topping analysts' consensus estimates of $-0.14 by $0.03. The company had revenue of 7.33 M for the quarter and had revenue of 31.91 M for the year. Enzo Biochem, Inc. has generated $-1 earnings per share over the last year ($-0.51 diluted earnings per share) and currently has a price-to-earnings ratio of -0.77. Enzo Biochem, Inc. has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Wednesday, June 11th, 2025 based on prior year's report dates.
Enzo Biochem, Inc. Earnings History by Quarter
| Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue |
|---|---|---|---|---|---|---|
| 03/17/2025 | Q2 2025 | N/A | -$0.03 | N/A | $21.01 M | $7.33 M |
| 12/16/2024 | Q1 2025 | N/A | -$0.06 | N/A | $21.01 M | $6.21 M |
| 10/29/2024 | Q4 2024 | N/A | -$0.26 | N/A | $7.53 M | $7.53 M |
| 06/13/2024 | Q3 2024 | N/A | -$0.06 | N/A | $34.19 M | $8.02 M |
| 03/13/2024 | Q2 2024 | N/A | -$0.06 | N/A | N/A | $8.55 M |
| 12/15/2023 | Q1 2024 | N/A | -$0.13 | N/A | N/A | $7.81 M |
| 11/28/2023 | Q4 2023 | N/A | $0.25 | N/A | $19.66 M | $-19,660,000 |
| 06/14/2023 | Q3 2023 | N/A | -$0.30 | N/A | $19.31 M | $16.11 M |
| 03/20/2023 | Q2 2023 | N/A | -$0.22 | N/A | $21.01 M | $16.34 M |
| 12/12/2022 | Q1 2023 | N/A | -$0.26 | N/A | N/A | $18.28 M |
| 10/14/2022 | Q4 2022 | N/A | $0.03 | N/A | N/A | $20.28 M |
| 06/09/2022 | Q3 2022 | N/A | -$0.19 | N/A | $28.26 M | $26.22 M |
| 03/14/2022 | Q2 2022 | N/A | -$0.05 | N/A | N/A | $34.05 M |
| 12/15/2021 | Q1 2022 | N/A | -$0.05 | N/A | N/A | $26.52 M |
| 10/12/2021 | Q4 2021 | N/A | $0.18 | N/A | N/A | $24.81 M |
| 06/11/2021 | Q3 2021 | N/A | $0.04 | N/A | $22.34 M | $32.80 M |
| 03/16/2021 | Q2 2021 | N/A | $0.05 | N/A | N/A | $31.47 M |
| 12/11/2020 | Q1 2021 | N/A | $0.01 | N/A | N/A | $28.66 M |
| 10/19/2020 | Q4 2020 | N/A | -$0.07 | N/A | N/A | $19.53 M |
| 06/09/2020 | Q3 2020 | N/A | -$0.21 | N/A | $17.66 M | $16.90 M |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
Enzo Biochem, Inc. Earnings: FAQ's
Enzo Biochem, Inc. has not confirmed its next earnings publication date, but the company's estimated earnings date is Wednesday, June 11th, 2025 based offlast year's report dates.
In the previous quarter, Enzo Biochem, Inc. (:ENZ) reported $-0.11 earnings per share (EPS) to beat the analysts' consensus estimate of $-0.14 by $0.03.
The conference call for Enzo Biochem, Inc.'s latest earnings report can be listened to online.
The conference call transcript for Enzo Biochem, Inc.'s latest earnings report can be read online.
Enzo Biochem, Inc. (:ENZ) has a recorded annual revenue of $31.91 M.
Enzo Biochem, Inc. (:ENZ) has a recorded net income of $-26,078,000.Enzo Biochem, Inc. has generated $-0.51 earnings per share over the last four quarters.
Enzo Biochem, Inc. (:ENZ) has a price-to-earnings ratio of -0.77 and price/earnings-to-growth ratio is -0.11.